Nexentis Technologies (NXTS) EBIT Margin (2019 - 2025)
Nexentis Technologies' EBIT Margin came in at -66300.00% for Q3 2025, down 50344.44 percentage points from -15955.56% a year earlier.
Powered by 
Analysis
Nexentis Technologies (NXTS) EBIT Margin (2019 - 2025) Analysis & Trends
Over the trailing twelve months to Sep 30, 2025, Nexentis Technologies reported EBIT Margin of -2292.34%, up 740.52 percentage points year-over-year; for FY2024, it came in at -1563.33%, up 1318.04 percentage points from FY2023.
- EBIT Margin carries a five-year change of -464.90 percentage points (FY2019 to FY2024).
- Going back by year, EBIT Margin was -2881.37% in FY2023 (-1404.32 pp), -1477.05% in FY2022 (-403.51 pp), -1073.54% in FY2021 (-492.62 pp) and -580.93% in FY2020 (+517.51 pp).
- The Q3 2025 figure represents the lowest quarterly EBIT Margin in data going back to Q1 2019.
- Year-over-year, EBIT Margin increased in two of the last six quarters, with an average year-over-year change of -8674.30 percentage points.
- The fastest year-over-year change in EBIT Margin over five years came in Q4 2024 (a gain of 1872.64 percentage points), and the weakest in Q3 2025 (a drop of 50344.44 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Nexentis Technologies | 1.20 Mn | -21.57 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -66,300.00% |
| Mar 31, 2025 | -937.88% |
| Dec 31, 2024 | -155.32% |
| Sep 30, 2024 | -15,955.56% |
| Jun 30, 2024 | -4,982.35% |
| Mar 31, 2024 | -2,043.18% |
| Dec 31, 2023 | -2,027.96% |
| Jun 30, 2023 | -2,295.45% |
| Mar 31, 2023 | -1,440.92% |
| Dec 31, 2022 | -637.86% |
| Sep 30, 2022 | -3,450.59% |
| Jun 30, 2022 | -4,108.53% |
| Mar 31, 2022 | -1,535.63% |
| Dec 31, 2021 | -830.25% |
| Sep 30, 2021 | -1,811.17% |
| Jun 30, 2021 | -2,981.71% |
| Mar 31, 2021 | -200.59% |
| Dec 31, 2020 | -89.90% |
| Mar 31, 2020 | -569.27% |
| Dec 31, 2019 | -1,198.43% |
API Access
Nexentis Technologies EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=NXTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "NXTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=NXTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();